ArticleAddiction (Abingdon, England)2018
Increased non-fatal overdose risk associated with involuntary drug treatment in a longitudinal study with people who inject drugs.
Article in Addiction (Abingdon, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.
- Assessing HIV and overdose risks for people who use drugs exposed to compulsory drug abstinence programs (CDAP): A systematic review and meta-analysis.The International journal on drug policy · 2021Pooled it
- Municipal police support for harm reduction services in officer-led referrals of people who inject drugs in Tijuana, Mexico.Harm reduction journal · 2021Trial
- Higher prevalence of non-fatal overdose with opioid and stimulant use compared to use of opioids alone.Drug and alcohol dependence · 2026Article
- Article
- Study Protocol on Rapid Measurement of Novel Harm Reduction Housing on HIV Risk, Treatment Uptake, Drug Use, and Supply.Substance use & addiction journal · 2025Article
- Use and perceptions of involuntary civil commitment among post-overdose outreach staff in Massachusetts, United States: A mixed-methods study.Addiction (Abingdon, England) · 2025Article
- An exploration of desired abstinent and non-abstinent recovery outcomes among people who use methamphetamine.Harm reduction journal · 2025Article
- Views and experiences of involuntary civil commitment of people who use drugs in Massachusetts (Section 35).Drug and alcohol dependence · 2024Article
- Drug Overdose Death Following Substance Use Disorder Treatment Termination in New York City: A Retrospective Longitudinal Cohort Study.Journal of urban health : bulletin of the New York Academy of Medicine · 2024Article
- 'It was like coming back from the clouds': a qualitative analysis of the lived experience of overdose consequent to drug use among a cohort of people who use drugs in Scotland.Harm reduction journal · 2024Article
- Analyzing and predicting short-term substance use behaviors of persons who use drugs in the great plains of the U.S.PloS one · 2024Article
- Characteristics of post-overdose outreach programs and municipal-level opioid overdose in Massachusetts.The International journal on drug policy · 2023Article
- Intersections between syndemic conditions and stages along the continuum of overdose risk among women who inject drugs in Mexicali, Mexico.Harm reduction journal · 2023Article
- Correlates of recent overdose among people who inject drugs in the San Diego/Tijuana border region.Drug and alcohol dependence · 2022Article
- Prevalence and risk factors for opioid related mortality among probation clients in an American city.Journal of substance abuse treatment · 2022Article
- Opinion: Public health and police: Building ethical and equitable opioid responses.Proceedings of the National Academy of Sciences of the United States of America · 2021Article
- Investigating a bidirectional relationship between overdose and provision of injection initiation assistance among persons who inject drugs in Vancouver, Canada and Tijuana, Mexico.The International journal on drug policy · 2021Article
- Socially-supportive norms and mutual aid of people who use opioids: An analysis of Reddit during the initial COVID-19 pandemic.Drug and alcohol dependence · 2021Article
- Commentary on Fishman et al. : Youth and family-centered care for young adults with opioid use disorder.Addiction (Abingdon, England) · 2021Article
- Is hepatitis C virus (HCV) elimination achievable among people who inject drugs in Tijuana, Mexico? A modeling analysis.The International journal on drug policy · 2021Article
Corrections and comments
- Commented on by
Authors and funding
7 authors at 4 institutions in 4 countries.
Funding
Abstract
aimTo assess the effect of involuntary drug treatment (IDT) on non-fatal overdose among people who inject drugs (PWID).
designLongitudinal study.
settingTijuana, Mexico.
participantsBaseline sample of 671 PWID included 258 (38.4%) women and 413 (61.6%) men. MEASUREMENTS: Primary independent variables were reported recent (i.e. past 6 months) non-fatal overdose event (dependent variable) and IDT. Substance use the day of the non-fatal overdose was also examined.
findingsFrom 2011 to 2017, 213 participants (31.7%) reported a recent non-fatal overdose and 103 (15.4%) reported recent IDT. Heroin, in combination with methamphetamine and tranquilizers, were the drugs most reported at the day of the event. IDT significantly increased the odds of reporting a non-fatal overdose event [adjusted odds ratio (aOR) = 1.76; 95% confidence interval (CI) = 1.04-2.96]. Odds of non-fatal overdose also increased independently for each additional injection per day (aOR = 1.05; 95% CI = 1.02-1.08), recent tranquilizer use (aOR = 1.92; 95% CI = 1.41-2.61) and using hit doctors (aOR = 1.68; 95% CI = 1.29-2.18) and decreased with age (aOR = 0.97 per year, 95% CI = 0.95-0.99).
conclusionsRecent involuntary drug treatment in Mexico is a risk factor for non-fatal drug overdose.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.